-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
November 02, 2018 - Limitations in the accuracy of the clinical diagnosis of AD as the underlying cause of CATD,
even after … Published in full text in peer reviewed journals
Language of
Publication
English only, due to resource limitations … The five required strength of evidence domains will be: (1)
study limitations; (2) directness; (3) consistency … studies, unmeasured confounders that would decrease an effect, and strength of
association.29
Study limitations … Small studies: strengths and limitations.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
June 21, 2019 - The study may be missing
information, making it difficult to assess limitations and potential problems … .34 To ensure consistency and validity of the
evaluation, the grades will be reviewed for:
• Study limitations … (low, medium, or high level of study limitations)
• Consistency (consistent, inconsistent, or unknown
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
March 21, 2016 - Our intent was in describing limitations
common in available literature. No changes made. … TEP #5 Results p. 61: "Studies had methodological limitations and estimates were
imprecise." … Would you consider creating more structure in this
section so that your conclusions analysis of limitations … Perhaps it would also be good to add in
both places that the reasons for (or the benefits and limitations … The reasons and associated limitations would then have
to be added in those places.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-dispositIon-comments-2022.pdf
January 01, 2022 - If so, the authors should provide a
rationale for doing so, given the noted limitations of
this approach … The limitations are
described adequately.
1. … Limitations described. No response needed. … #1: Sunny
Etheridge
General The conclusion summarized the data well and explained
some of the limitations
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
January 01, 2020 - • Evidence is low or insufficient for other interventions
due to lack of studies or their limitations … Limitations
Limitations of this review include using only
English language articles and studies applicable … insufficient for most other interventions
and outcomes because of the lack of studies and
methodological limitations
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
May 20, 2022 - at the conclusion
that scoring every aspect
of apps didn’t seem
feasible, especially given
the limitations … One of the continued challenges and limitations of this and other existing
frameworks is that they do … We agree with this
observation and have
added this issue to the
limitations section of the
discussion … We
have added this issue to
the limitations of the
framework.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
September 01, 2009 - .
+ Low: Few (≤2) trials exist, existing trials have inconsistent results and/or limitations, results … by future research.
+ Low: Few (≤2) trials exist, existing trials have inconsistent results and/or limitations
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - of attending followup appointments with you
and other health care providers
Gaps in Knowledge and Limitations … of the
Evidence Base
Several gaps and limitations were identified in the evidence base
reviewed for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_clinician.pdf
March 01, 2016 - Gaps in Knowledge and Limitations of the
Evidence Base
Several gaps and limitations were identified
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - Despite these limitations, we found that
uterine artery embolization (UAE) (high SOE) as well
as HIFU … See “Limitations
of the Evidence Base” in the full report for further
discussion.
KQ4. … While there are limitations in the literature as discussed
below, the information that is available … Limitations of the Systematic Review Process
Methodologic choices constrain the findings of this
report … Limitations about leiomyosarcoma data: Because cases
are rare and detailed age data for non-cases is
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
March 21, 2013 - Commentator &
Affiliation Section Comment Response
Peer Reviewer #3 Discussion/Conclusion The limitations … The authors discussed
not only the applicability of the findings summaries, but also
possible limitations … Peer Reviewer #4 Discussion/Conclusion The limitations section as well as the Future Research section … Peer Reviewer #6 Discussion/Conclusion The implications of major findings are clear and the limitations … We feel it is
helpful to point out limitations,
inconsistencies, and intriguing findings.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
April 11, 2018 - The domains to be used for all KQs will be: the methodological
limitations of the studies (i.e., risk … We will report any limitations in applicability of
12
individual studies in evidence tables … and limitations of applicability of the whole body of
evidence in the summary of evidence tables.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease-appendix-a.pdf
August 31, 2023 - Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease
Ovid
Database(s): EBM Reviews - Cochrane Central Register of Controlled Trials July 2023, Embase
1974 to 2023 August 31, Ovid MEDLINE(R) and Epub Ahead of Print, In-Process, In-Data-
Review & Other Non-Indexed Citat…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-appendix-a.pdf
August 31, 2023 - Ovid
Database(s): EBM Reviews - Cochrane Central Register of Controlled Trials July 2023, Embase
1974 to 2023 August 31, Ovid MEDLINE(R) and Epub Ahead of Print, In-Process, In-Data-
Review & Other Non-Indexed Citations, Daily and Versions 1946 to August 31, 2023
Search Strategy:
# Searches Results
1 exp Diabete…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-disposition-comments.pdf
April 07, 2025 - : “ We also
added further explanation to section 4.8 about the
limitations of our assessment of … We have
acknowledged this as a limitation in our discussion on
strengths and limitations.
60 KI … We recognize though the limitations of this
approach in identifying other papers. … We recognize these
limitations and raise this in our discussion section 4.8
on strengths and limitations … We recognize the limitations of our
https://effectivehealthcare.ahrq.gov/products/pqmp/tech-brief